Puisis recently spoke with MM+M about the funding raise, the condition of the autoimmune treatment space and the potential of Chicago’s ascendant biotech scene.
Patients see first savings from Biden’s drug price push, as pharma lines up its lawyers
A restructuring of the Medicare drug benefit has wiped out big drug price bills for people who need expensive medicines. But the legal battle over drug negotiations means uncertainty over long-term savings.
FDA’s Marks says CAR-T safety probe ‘probably’ found causal link to lymphoma
The release of added context on the benefit-risk profile of CAR-T therapies underscores how safety is moving from the periphery into the category’s forefront.
Azurity Pharmaceuticals recalls ADHD drug Zenzedi after bottle mistake
Collette Douaihy’s appointment as president of the Pharma Lions comes after the Dentsu team enjoyed a successful trip to the French Riviera, earning the Pharma Lions Grand Prix for Scrolling Therapy.
AARP lists 10 prescription drugs with excessive price increases
AARP’s findings reflect a world prior to the passage and enactment of the Inflation Reduction Act of 2022, which requires drug manufacturers to pay rebates to Medicare if their drug prices increase faster than inflation.
NYT story renews concerns over asthma drug Singulair’s psychiatric risks